Local level of TGF-β1 determines the effectiveness of dexamethasone through regulating the balance of Treg/Th17 cells in TNBS-induced mouse colitis.

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Experimental and Therapeutic Medicine

• Publication date

  2018-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3892/etm.2018.5852PMID 29545894PMCID PMC5840944
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Regulation of human helper T cell subset differentiation by cytokines.

  2015cited by this paper
• Vacuolar protein sorting 4B regulates apoptosis of intestinal epithelial cells via p38 MAPK in Crohn's disease.

  2015cited by this paper
• Inflammatory Bowel Disease: An Overview of Immune Mechanisms and Biological Treatments

  2015cited by this paper
• A potential role for regulatory T-cells in the amelioration of DSS induced colitis by dietary non-digestible polysaccharides.

  2015cited by this paper
• Experimental evidence of heparanase, Hsp70 and NF-κB gene expression on the response of anti-inflammatory drugs in TNBS-induced colonic inflammation.

  2015cited by this paper
• Understanding inflammatory bowel disease via immunogenetics.

  2015cited by this paper
• Inflammatory bowel disease: the classic gastrointestinal autoimmune disease.

  2014cited by this paper
• Cytokines in inflammatory bowel disease

  2014cited by this paper
• Transforming growth factor β1 (TGFβ1) in physiology and pathology.

  2013cited by this paper
• Dexmedetomidine ameliorates TNBS-induced colitis by inducing immunomodulator effect.

  2013cited by this paper
• TGF-Beta signaling manipulation as potential therapy for IBD.

  2013cited by this paper
• The JNK Inhibitor XG-102 Protects against TNBS-Induced Colitis

  2012cited by this paper
• Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review.

  2012cited by this paper
• Regulatory T‐cell therapy for inflammatory bowel disease: more questions than answers

  2012cited by this paper
• TH17 Cells in Autoimmunity and Immunodeficiency: Protective or Pathogenic?

  2012cited by this paper
• KSR1 protects from interleukin-10 deficiency-induced colitis in mice by suppressing T-lymphocyte interferon-γ production.

  2011cited by this paper
• Proinflammatory cytokines in the pathogenesis of inflammatory bowel diseases.

  2011cited by this paper
• Role of transforming growth factor‐&bgr; in inflammatory bowel disease and colitis‐associated colon cancer

  2010cited by this paper
• Has the Microbiota Played a Critical Role in the Evolution of the Adaptive Immune System?

  2010cited by this paper
• TGF-β1 and Smad7 in the regulation of IBD

  2008cited by this paper
• TGF-β and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain TH-17 cell–mediated pathology

  2007cited by this paper
• Induction of alkaline phosphatase in the inflamed intestine: a novel pharmacological target for inflammatory bowel disease.

  2004cited by this paper
• TGF-beta1 production in inflammatory bowel disease: differing production patterns in Crohn's disease and ulcerative colitis.

  2003cited by this paper
• Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

  2001cited by this paper
• Treatment of experimental (Trinitrobenzene sulfonic acid) colitis by intranasal administration of transforming growth factor (TGF)-beta1 plasmid: TGF-beta1-mediated suppression of T helper cell type 1 response occurs by interleukin (IL)-10 induction and IL-12 receptor beta2 chain downregulation.

  2000cited by this paper
• A chronic ulcerative colitis model in rats.

  2000cited by this paper
• Review article: issues in oral administration of locally acting glucocorticosteroids for treatment of inflammatory bowel disease

  1998cited by this paper
• Transforming growth factor-beta gene therapy ameliorates experimental colitis in rats.

  1995cited by this paper
• Characterization of mechanisms involved in transrepression of NF-kappa B by activated glucocorticoid receptors

  1995cited by this paper
• Phenotypically distinct subsets of CD4+ T cells induce or protect from chronic intestinal inflammation in C. B-17 scid mice.

  1993cited by this paper
• An orally active inhibitor of leukotriene synthesis accelerates healing in a rat model of colitis.

  1990cited by this paper

• Dual Role of the Endometrial Microbiome-Immune Axis: From Endometrial Homeostasis to Reproductive Disorders.

  2026cites this paper
• Elucidating the potential mechanism and therapeutic targets of chronic stress-induced muscle atrophy.

  2025cites this paper
• Transcutaneous vagus nerve stimulation ameliorates cardiac abnormalities in chronically stressed rats

  2023cites this paper
• “Iron triangle” of regulating the uterine microecology: Endometrial microbiota, immunity and endometrium

  2022influential citation
• Advances in Pathogenesis and Treatment of Asthmatic Bronchial Pneumonia in Children

  2022cites this paper
• Mechanism of miR-181a-5p in Regulatory T/T-Helper 17 Immune Imbalance and Asthma Development in Mice with Allergic Rhinitis

  2021cites this paper
• The Role of Glucocorticoids in Inflammatory Diseases

  2021cites this paper
• From Suppressor T Cells to Regulatory T Cells: How the Journey that Began with the Discovery of the Toxic Effects of TCDD Led to Better Understanding of the Role of AhR in Immunoregulation

  2020cites this paper
• A recombinant protein rLZ‐8, originally extracted from Ganoderma lucidum, ameliorates OVA‐induced lung inflammation by regulating Th17/Treg balance

  2020cites this paper
• Differential Expression of SMAD Genes and S1PR1 on Circulating CD4+ T Cells in Multiple Sclerosis and Crohn’s Disease

  2020cites this paper
• Context-Dependent Effect of Glucocorticoids on the Proliferation, Differentiation, and Apoptosis of Regulatory T Cells: A Review of the Empirical Evidence and Clinical Applications

  2019cites this paper
• JAK-inhibitors in dermatology: current evidence and future applications

  2018cites this paper